New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
16:50 EDTMNKDMannKind says it is in talks with partners for Afrezza
MannKind says it is in talks with partners for Afrezza and the company sees needing 6 to 8 weeks post the drug's PDUFA date to finalize any partnerships, which it expects to be royalty based or profit sharing arrangments. MannKind sees pricing Affrezza comparable to injected insulin. MannKind notes that the PDUFA date for Afrezza is July 15. Comments made earlier by CFO Matthew Pfeffer at the Goldman Sachs Global Healthcare conference.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2015
09:56 EDTMNKDOptions with increasing volume on open
Subscribe for More Information
09:03 EDTMNKDMannKind triples production capacity for Afrezza
MannKind announced that it has completed the validation of two additional filling lines for the manufacture of Afrezza inhalation powder. Material produced during the validation runs, including the recently approved 12 unit cartridges, will be supplied to Sanofi to support the launch of the new dosage strength, which is expected later this quarter.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use